Glutamic Acid Decarboxylase Antibodies in patients with diabetes Type 2 Epstein-Barr virus-related Infection
MAJID HADI JASIM, HEIDER HEMEED ABBAS, SUMAYA NAJIM AL-KHATEEB, SAIF JABBAR YASIR, AMAL MERZA HASAN, FATIN NAJI ATYAA6
935
ABSTRACT
Background:
In order to function normally, the
pancreas needs GAD. GAD antibodies are named antibodies that target this
enzyme. GAD antibodies belong to a category of diabetes-related antibodies that
advise the immune system to kill insulin-producing pancreatic cells. When development of insulin ceases, diabetes
develops. The researchers reported that
the existence of Epstein Barr virus (EBV) increases the risk of seven
autoimmune diseases, including inflammatory bowel disease, celiac disease, and
diabetes, in a person.
Aim: To establish the
relationship between
the existence of GAD
antibodies and viral infections in diabetic patients.
Methods: Blood samples of 180 diabetic patients
and 150 healthy individuals in the control group involved males and females
were examined for the existence of GAD antibodies and viral infections using
ELISA to defect GAD and EBV antibodies and PCR for viral nucleic acid detection
techniques.
Result: Type 1 diabetes was 57%, while Type 2 patients
were 34%. It turns out that females have
higher rates of type 1 diabetes than males, whereas males have higher rates of
type 2 diabetes than females. Positive
findings showed a 49% association between type diabetes and GAD test results
and EBV IgM antibodies. The first form
of diabetes showed 37% positive anti-GAD test samples. ELISA technique
indicated that 37 percent of the overall antiviral IgM antibodies involved 24.2
percent positive samples for the body of EBV IgM, while diabetics reported
second form positive samples for anti-GAD testing and 53.2 percent positive
samples for EBV IgM antibodies. 37 percent positive results were observed when
ELISA was used to evaluate IgM antibodies. When testing ELISA for the IgG
antiviral antibody test, it was found that 90% of the samples had positive
results. Type 1 diabetes reported 64 per cent positive samples for anti-GAD
screening and 86.4 per cent positive samples for the body of EBV IgG, while 83
per cent positive samples for type 2 EBV testing were shown. According to the PCR technique, the results
showed that 33.3 per cent of the samples had positive results in all diabetic patients,
particularly those with anti-GAD antibodies.
Conclusion: This study concluded that high virus infectivity might indicate the
relationship between EBV infection and development of anti-GAD antibodies.
Keyword: Diabetic Mellitus, GAD
anti, EBV, ELISA, PCR.
ABSTRACT
Background:
In order to function normally, the
pancreas needs GAD. GAD antibodies are named antibodies that target this
enzyme. GAD antibodies belong to a category of diabetes-related antibodies that
advise the immune system to kill insulin-producing pancreatic cells. When development of insulin ceases, diabetes
develops. The researchers reported that
the existence of Epstein Barr virus (EBV) increases the risk of seven
autoimmune diseases, including inflammatory bowel disease, celiac disease, and
diabetes, in a person.
Aim: To establish the
relationship between
the existence of GAD
antibodies and viral infections in diabetic patients.
Methods: Blood samples of 180 diabetic patients
and 150 healthy individuals in the control group involved males and females
were examined for the existence of GAD antibodies and viral infections using
ELISA to defect GAD and EBV antibodies and PCR for viral nucleic acid detection
techniques.
Result: Type 1 diabetes was 57%, while Type 2 patients
were 34%. It turns out that females have
higher rates of type 1 diabetes than males, whereas males have higher rates of
type 2 diabetes than females. Positive
findings showed a 49% association between type diabetes and GAD test results
and EBV IgM antibodies. The first form
of diabetes showed 37% positive anti-GAD test samples. ELISA technique
indicated that 37 percent of the overall antiviral IgM antibodies involved 24.2
percent positive samples for the body of EBV IgM, while diabetics reported
second form positive samples for anti-GAD testing and 53.2 percent positive
samples for EBV IgM antibodies. 37 percent positive results were observed when
ELISA was used to evaluate IgM antibodies. When testing ELISA for the IgG
antiviral antibody test, it was found that 90% of the samples had positive
results. Type 1 diabetes reported 64 per cent positive samples for anti-GAD
screening and 86.4 per cent positive samples for the body of EBV IgG, while 83
per cent positive samples for type 2 EBV testing were shown. According to the PCR technique, the results
showed that 33.3 per cent of the samples had positive results in all diabetic patients,
particularly those with anti-GAD antibodies.
Conclusion: This study concluded that high virus infectivity might indicate the
relationship between EBV infection and development of anti-GAD antibodies.
Keyword: Diabetic Mellitus, GAD
anti, EBV, ELISA, PCR.